Trasylol®
Manufacturer:
Bayer Pharmaceuticals
Uses: Injectable medication used to prevent excessive blood loss during heart surgery.
More Information
 |
| Trasylol |
A recent national study has found that the drug Trasylol may be linked to
serious complications including kidney failure and heart problems. The study
found that the drug increases the risk of heart failure and heart attack by
nearly 55%. The study examined 4,374 heart surgery patients worldwide and found
that those on Trasylol were at twice the risk of suffering kidney failure, a
heart attack or heart failure.
Trasylol was approved in 1993 by the FDA and is commonly used to reduce blood
loss and the need for blood transfusion in patients undergoing heart surgery. It
is estimated that Trasylol may have been given to as many as 1 million patients
since its approval by the FDA.
If you or someone you know has experienced renal failure that requires
dialysis treatment after a Coronary Artery Bypass Graft or CABG surgery, you may
be entitled to substantial monetary compensation. Please
contact us for more information.
Side Effects
- Increased heart rate
- Difficulty breathing or shortness of breath
- Skin irritation and inflammation
- Nausea and vomiting
- Sudden chest, leg, head, or groin pain
- Swelling of the face, lips, tongue, or neck
For more information:
Pharmaceutical Litigation
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
|
